DEVICE FOR INTERNAL AND EXTERNAL NASAL APPLICATION
20220387389 · 2022-12-08
Inventors
Cpc classification
A61K36/899
HUMAN NECESSITIES
A61K36/22
HUMAN NECESSITIES
A61K9/06
HUMAN NECESSITIES
A61P17/02
HUMAN NECESSITIES
A61K31/23
HUMAN NECESSITIES
A61K31/35
HUMAN NECESSITIES
A61K47/44
HUMAN NECESSITIES
A61K31/569
HUMAN NECESSITIES
A61K36/54
HUMAN NECESSITIES
A61P17/16
HUMAN NECESSITIES
A61M35/003
HUMAN NECESSITIES
A61K31/045
HUMAN NECESSITIES
A61K36/47
HUMAN NECESSITIES
A61M11/00
HUMAN NECESSITIES
A61K9/0014
HUMAN NECESSITIES
International classification
A61K31/045
HUMAN NECESSITIES
A61K31/23
HUMAN NECESSITIES
A61K31/35
HUMAN NECESSITIES
A61K31/569
HUMAN NECESSITIES
A61K36/22
HUMAN NECESSITIES
A61K36/47
HUMAN NECESSITIES
A61K36/54
HUMAN NECESSITIES
A61K36/899
HUMAN NECESSITIES
A61K9/00
HUMAN NECESSITIES
Abstract
A combination product comprising a dispensing head (10, 10′) mounted on a top of a container (20, 20′) containing a formulation for nasal administration, and a solidified skin-care balm (50) for application around the nose contained in a balm holder element (30, 30″) located on a bottom (24) of the container (20).
Claims
1. A combination product comprising a dispensing head (10, 10′) mounted on a top of a container (20, 20′) containing a formulation for nasal administration, and a solidified skin-care balm (50) for application around the nose contained in a balm holder element (30, 30″) located on a bottom (24) of the container (20).
2. A combination product according to claim 1, wherein the dispensing head (10, 10′) is a metered dose spray pump.
3. A combination product according to claim 1, wherein the balm holder element (30, 30″) comprises a base element (34, 34′, 34″) on which the balm (50) is mounted, and a balm cover (32, 32″) with a cylindrical portion (33, 33″) surrounding the balm (50), and a cover portion (36, 36″).
4. A combination product according to claim 3, wherein the cylindrical portion (33, 33″) of the balm cover (32, 32″) is aligned with a cylindrical wall (22, 22′) of the container (20, 20′) containing the formulation.
5. A combination product according to claim 3, wherein the balm cover (32) is attached to the bottom (24) of the container.
6. A combination product according to claim 5, wherein the balm cover (32) is glued to the bottom (24) of the container (20, 20′).
7. A combination product according to claim 3, wherein the cover portion (36) is dome-shaped and matches a recess in the bottom (24) of the container (20) containing the formulation.
8. A combination product according to claim 3, wherein the balm cover is clipped or snap-fitted to the bottom (24) of the container.
9. A combination product according to claim 1, wherein the base element (34″) is attached to the bottom (24) of the container (20′).
10. A combination product according to claim 1, wherein the liquid formulation comprises a saline solution and/or an active ingredient selected from the group of vasoconstrictors, antiallergic agents and corticosteroids.
11. A combination product according to claim 10, wherein the active ingredient is xylometazoline or a pharmaceutically acceptable salt thereof.
12. A combination product according to claim 1, wherein the balm comprises an active ingredient having skin soothing properties, in particular selected from the group comprising ectoin, dexpanthenol, aloe vera, calendula, bisabolol and niacinamide.
13. A combination product according to claim 1, wherein the solidified balm (50) has substantially a hemispherical shape.
14. A combination product according to claim 1, wherein the balm comprises one or several skin conditioning agents.
15. A combination product according to claim 1, wherein the balm (50) comprises an active ingredient that is a botanical extract.
16. A balm holder element (30, 30″) comprising: a base element (34, 34′, 34″) on which a balm (50) is mounted, a balm cover (32, 32″) with a cylindrical portion (33, 33″) surrounding the balm (50), and a cover portion (36, 36″), wherein the balm holder element (30, 30″) is attachable to a nasal spray dispenser.
17. A method for treating nasal discomfort whereby a cooling and soothing effect is provided to a perinasal skin area, comprising the step of using the combination product according to claim 1 by applying the balm (50) to the perinasal skin area and administering the formulation for nasal administration into a nostril.
18. A method for treating runny nose whereby irritated skin is soothed, comprising the step of using the combination product according to claim 1 by applying the balm (50) to an irritated perinasal skin area and administering the formulation for nasal administration into a nostril.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0084] The invention will now be described by way of example only with reference to the accompanying figures.
[0085]
[0086]
[0087] The balm 50 has a substantially hemispherical shape, and an example for a formulation is given in Table 1.
[0088] The balm cover 32 consists of a cylindrical portion 33 surrounding the balm 50, and a cover portion 36 which has a domed shape, as it can be seen in
[0089] On the outer surface of the rim 52, several protrusions 56 are foreseen, which make a snap-fit connection with the cylindrical portion 33 of the balm cover 32 and help to keep the base element 34 connected to the balm cover 32, and thus to the container 20.
[0090]
[0091]
[0092]
Example 1
[0093] An example for a balm formulation is given below in Table 1.
TABLE-US-00001 TABLE 1 Example of a balm formulation % of component in INCI name of the final Function of component formulation the component OCTYLDODECANOL 17.00 EMOLLIENT CAPRYLIC/CAPRIC 14.70 SKIN CONDITIONING TRIGLYCERIDE RICINUS COMMUNIS 14.30 SKIN CONDITIONING SEED OIL ORYZA SATIVA 14.00 SKIN CONDITIONING CERA SKIN PROTECTING SMOOTHING RHUS VERNICIFLUA 13.40 EMOLLIENT PEEL CERA/RHUS STABILISING/ SUCCEDANEA BINDING FRUIT CERA EMOLLIENT THEOBROMA CACAO 7.00 EMOLLIENT SEED BUTTER SKIN CONDITIONING PERSEA GRATISSIMA 5.00 SKIN CONDITIONING OIL CETEARYL ALCOHOL 3.00 EMOLLIENT EMULSIFYING EMULSION STABILISING MYRISTYL MYRISTATE 3.00 EMOLLIENT SKIN CONDITIONING POLYGLYCERYL-3 2.50 EMULSIFYING DIISOSTEARATE CETYL ESTERS 2.00 EMOLLIENT SKIN CONDITIONING BUTYROSPERMUM 2.00 SKIN CONDITIONING PARKII BUTTER OLEYL ALCOHOL 0.48 EMOLLIENT MASKING ZANTHOXYLUM 0.12 SKIN CONDITIONING BUNGEANUM FRUIT EXTRACT TOCOPHERYL ACETATE 0.50 ANTIOXIDANT MENTHYL ETHYLAMIDO 0.50 SKIN CONDITIONING OXALATE Eucalyptol Nat 0.2 PERFUMING SKIN CONDITIONING MENTHOL 0.20 REFRESHING SOOTHING BHT 0.10 ANTIOXIDANT The names of the raw materials are given using the International Nomenclature of Cosmetic Ingredients (INCI). The % are indicated by weight.
[0094] The balm may be prepared by a conventional method. For the example, it was prepared by melting of the solid components in a water bath at a temperature sufficiently high to melt all ingredients, about 60° C.-70° C. Subsequently, the liquid ingredients were added, and the mixture was stirred to form a bulk. Any volatile ingredients were added after letting the bulk cool under stirring, but whilst the bulk was still fluid. The fluid bulk was poured into a stainless steel mould with an array of recesses of hemispheric shape. Excess bulk was scraped off. The mould filled with the bulk was let cool down at 5° C. for 20 minutes. The solidified balm hemispheres were removed from the mould by turning it upside down and placing it on a hard surface. To produce the combination product, the balm was pressed on the base element (34, 34′) and the base element was assembled with the remaining parts of the balm holder element (30, 30″) and the container containing the formulation for nasal administration.
TABLE-US-00002 TABLE 2 Examples of formulations for nasal administration Amount Ingredient Function (% w/w) Example for a liquid formulation comprising a corticosteroid Fluticasone Propionate Active 0.05 Micronised Dextrose Anhydrous Osmolarity agent 5 Phenylethyl Alcohol USP Preservative 0.25 Avicel RC591 (GI) Suspending agent 1.50 Benzalkonium Chloride Preservative 0.02 EP/USNF/JP Polysorbate 80 (GI) Wetting agent 0.005 Purified Water Vehicle Ad 100.0 Example for a liquid formulation comprising a vasoconstrictor Xylometazoline Hydrochloride Active Ingredient 0.1 Sodium dihydrogen phosphate Buffering Agent 0.28 dihydrate Disodium phosphate Buffering Agent 0.3 dodecahydrate Disodium edetate Chelating agent 0.05 Benzalkonium Chloride Preservative 0.01 Sodium Chloride Isotonicity regulator 0.7 Purified water Vehicle Ad 100 Example for a liquid formulation comprising a vasoconstrictor and a moisturizing agent Oxymetazoline Hydrochloride Active Ingredient 0.05 Sodium dihydrogen phosphate Buffering Agent 0.2 dihydrate Disodium phosphate dodecahydrate Buffering Agent 0.28 Disodium edetate Chelating agent 0.05 Benzalkonium Chloride Preservative 0.01 Sorbitol 70% (non-crystallising) Moisturizing Agent 1.4 Sodium Chloride Isotonicity regulator 0.5 Levomenthol Aroma 0.03 Cineol Aroma 0.02 Castor oil, polyoxyl hydrogenated Solubiliser 0.275 Purified water Vehicle ad 100